Breaking Down Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd. Financial Health: Key Insights for Investors

Breaking Down Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd. Financial Health: Key Insights for Investors

CN | Basic Materials | Chemicals | SHH

Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd. (600389.SS) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Curious whether Nantong Jiangshan Agrochemical & Chemicals (600389.SS) is a stable compound in your portfolio or a volatile reaction? Dive into hard numbers: H1 2025 revenue of CNY 3.167 billion (up 18.50% YoY) and TTM revenue of CNY 5.62 billion, net income for nine months to Sept 30, 2025 of CNY 425.2 million (vs CNY 171.52m a year earlier), a market cap near CNY 11.46 billion with a P/E around 19.8 and TTM EPS of CNY 1.11, alongside a balanced debt-to-equity of 0.51 but troubling free cash flow of CNY -889.42 million and an Altman Z-Score of 2.24; add a +42.76% 52-week price gain, a dividend yield of 0.91% (CNY 0.20/share), and forecasts for earnings and revenue growth of 39.1% and 18.7% per annum-read on to unpack valuation (P/S 2.04, P/B 2.19, EV/EBITDA 15.89), liquidity (current ratio 1.16, quick ratio 0.62), capital expenditure of CNY -1.42 billion TTM, exposure across 40 export markets, and the strategic drivers behind its multi-product growth story.

Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd. (600389.SS) Revenue Analysis

Nantong Jiangshan Agrochemical & Chemicals reported continued top-line expansion driven by steady product demand and operational scale. Key headline metrics and recent trends are summarized below.
  • H1 2025 revenue: CNY 3.167 billion (up 18.50% YoY)
  • 2024 annual revenue: CNY 5.43 billion (up 6.80% vs. 2023)
  • TTM revenue: CNY 5.62 billion (up 0.78% YoY)
  • Revenue per employee: ~CNY 2.07 million (2,721 employees)
  • Market capitalization: CNY 11.46 billion; P/S ratio: 2.04
Metric Value Notes
H1 2025 Revenue CNY 3,167,000,000 18.50% YoY increase
2024 Revenue (Annual) CNY 5,430,000,000 6.80% increase vs. 2023
TTM Revenue CNY 5,620,000,000 0.78% growth YoY
Employees 2,721 Used to calculate revenue per employee
Revenue per Employee CNY 2,070,000 (approx.) Revenue / employees
Market Capitalization CNY 11,460,000,000 Market value as reported
Price-to-Sales (P/S) 2.04 Market cap / TTM revenue
The mix of a strong H1 2025 performance and a modest TTM growth rate suggests seasonal or timing effects concentrated in the first half, while annual growth in 2024 indicates structural stability. Revenue per employee near CNY 2.07 million reflects reasonable operational productivity for the chemicals/agrochemical sector, supporting the company's P/S multiple given its market cap.
  • Stable revenue growth trend supports consistent demand for core products
  • H1 spike lifts short-term momentum; TTM shows slower sequential growth
  • Valuation (P/S ~2.04) implies market pricing that balances growth and sector risk
Exploring Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd. Investor Profile: Who's Buying and Why?

Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd. (600389.SS) - Profitability Metrics

Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd. reported strong year-over-year profitability improvements driven by higher sales and margin recovery. Key headline figures for recent periods highlight meaningful earnings growth, steady operating performance, and a shareholder-return profile that includes a modest dividend.
  • Net income (9 months ending Sep 30, 2025): CNY 425.2 million (vs CNY 171.52 million in same period 2024).
  • Trailing twelve months (TTM) EPS: CNY 1.11; P/E ratio: 19.76.
  • Return on equity (ROE): 11.43% - indicates efficient use of shareholders' equity.
  • Net profit margin: 8.45% - solid profitability for the sector.
  • Operating income (TTM): CNY 459.67 million; operating margin: 8.13%.
  • Dividend: CNY 0.20 per share annually; dividend yield: 0.91%.
Metric Value Period / Note
Net Income CNY 425.2 million 9 months ended Sep 30, 2025
Net Income (YoY Comparable) CNY 171.52 million 9 months ended Sep 30, 2024
EPS (TTM) CNY 1.11 Trailing twelve months
P/E Ratio 19.76 Based on TTM earnings
ROE 11.43% Return on equity
Net Profit Margin 8.45% Net income / Revenue
Operating Income (TTM) CNY 459.67 million Trailing twelve months
Operating Margin 8.13% Operating income / Revenue
Annual Dividend CNY 0.20 per share Dividend yield: 0.91%
  • Profit growth driver: sharp increase in net income YTD through Sep 30, 2025, signaling improved demand or better cost control.
  • Valuation context: P/E ~19.8 suggests market prices expected continued earnings stability; compare to peers for relative value.
  • Cash returns: modest dividend yield indicates priority may be on reinvestment or balance-sheet strength over high shareholder payouts.
Mission Statement, Vision, & Core Values (2026) of Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd.

Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd. (600389.SS) - Debt vs. Equity Structure

  • Debt-to-equity ratio: 0.51 - indicates a balanced financing mix between debt and equity.
  • Total debt: CNY 2.20 billion.
  • Cash and cash equivalents: CNY 1.46 billion.
  • Net cash position (net debt): CNY -742.39 million (i.e., net debt of CNY 742.39 million).
  • Interest coverage ratio: 18.07 - strong ability to service interest expense.
  • Total assets: CNY 9.44 billion; total liabilities: CNY 3.28 billion.
  • Equity (book value): CNY 4.37 billion; book value per share: CNY 9.51.
  • Capital expenditures (TTM): CNY -1.42 billion - sizeable investment activity.
Metric Amount (CNY) Interpretation
Total Assets 9,440,000,000 Scale of balance sheet
Total Liabilities 3,280,000,000 Claims against assets
Equity (Book Value) 4,370,000,000 Shareholders' residual interest
Book Value per Share 9.51 Per-share shareholder equity
Total Debt 2,200,000,000 Gross financial obligations
Cash & Cash Equivalents 1,460,000,000 Immediate liquidity
Net Cash Position (Net Debt) -742,390,000 Net debt of CNY 742.39M
Debt-to-Equity Ratio 0.51 Moderate leverage
Interest Coverage Ratio 18.07 Comfortable interest coverage
Capital Expenditures (TTM) -1,420,000,000 Significant capex outflow
  • Liquidity profile: with CNY 1.46B in cash against CNY 2.20B debt, near-term liquidity is adequate given high interest coverage.
  • Leverage stance: 0.51 debt-to-equity points to conservative-to-moderate leverage for a chemicals manufacturer.
  • Investment activity: negative CNY 1.42B capex (TTM) signals growth and capacity spending - monitor cash flow impact.
  • Balance sheet strength: equity of CNY 4.37B and total assets of CNY 9.44B provide a solid asset base to support operations and borrowing.
Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money

Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd. (600389.SS) - Liquidity and Solvency

Nantong Jiangshan's short- and medium-term financial resilience displays mixed signals: an adequate current ratio contrasts with a weak quick ratio, operating cash generation is positive while free cash flow is substantially negative, and solvency metrics point to moderate distress risk.
  • Current ratio: 1.16 - suggests the company has slightly more current assets than current liabilities to cover short-term obligations.
  • Quick ratio: 0.62 - indicates limited immediate liquidity once inventories are excluded, raising concerns about meeting very short-term liabilities without liquidating inventory.
  • Operating cash flow (TTM or latest period): CNY 533.85 million - positive cash from operations supports ongoing operations.
  • Free cash flow: CNY -889.42 million - significant negative FCF, implying heavy investment spending, debt servicing, or working-capital strain.
  • Net income (nine months ending Sep 30, 2025): CNY 425.2 million - profitable on the income-statement basis for the period.
  • Altman Z-Score: 2.24 - places the company in a zone of moderate bankruptcy risk (gray zone), not safe but not in imminent distress.
  • Piotroski F-Score: 5 - a neutral score indicating mixed fundamental signals (neither strongly healthy nor clearly deteriorating).
Metric Value Implication
Current Ratio 1.16 Adequate short-term coverage of liabilities
Quick Ratio 0.62 Potential difficulty meeting immediate obligations without inventory sales
Operating Cash Flow CNY 533.85 million Positive cash generation from core operations
Free Cash Flow CNY -889.42 million Negative FCF - cash outflows exceed operational inflows after capex
Net Income (9M to 2025-09-30) CNY 425.2 million Reported profitability for the nine-month period
Altman Z-Score 2.24 Moderate bankruptcy risk (gray zone)
Piotroski F-Score 5 Neutral fundamental health
  • Working-capital context: a current ratio near 1.2 but quick ratio below 1 highlights inventory reliance; inventory management and receivables collection are key operational levers.
  • Cash-flow dynamics: positive operating cash flow juxtaposed with deep negative free cash flow suggests high capital expenditures or cash used in investing/financing activities - monitor capex plans and financing terms.
  • Solvency monitoring: Altman Z-Score of 2.24 warrants tracking leverage, interest coverage, and profitability trends to detect any deterioration toward distress.
  • Fundamental signal mix: Piotroski F-Score of 5 implies investors should seek trend data (quarter-on-quarter) across profitability, leverage, liquidity, and operating efficiency to form a clearer stance.
For additional context on the company's strategic posture and guiding principles, see: Mission Statement, Vision, & Core Values (2026) of Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd.

Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd. (600389.SS) - Valuation Analysis

Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd. (600389.SS) presents a mixed valuation profile: market metrics show a premium to book value and moderate earnings multiples, while enterprise-value measures highlight relatively higher valuation versus cash generation.

  • Market capitalization: CNY 9.58 billion
  • Enterprise value (EV): CNY 10.59 billion
  • Trailing P/E: 20.10
  • Forward P/E: 18.77
  • Price-to-book (P/B): 2.19
  • EV/EBITDA: 15.89
  • EV/FCF: -11.91
  • Beta: 0.58
  • 52-week price change: +42.76%
Metric Value Implication
Market Cap CNY 9.58 billion Mid-cap scale on SSE; base for equity value
Enterprise Value CNY 10.59 billion Includes net debt; EV > market cap indicates net debt position
Trailing P/E 20.10 Moderate earnings multiple vs. domestic peers
Forward P/E 18.77 Market expects modest earnings growth or margin improvement
P/B 2.19 Trades at a premium to book - growth or intangible value priced in
EV/EBITDA 15.89 Relatively elevated, suggests limited EBITDA cushion for EV
EV/FCF -11.91 Negative FCF metric - caution on cash generation or timing effects
Beta 0.58 Lower volatility than broader market - defensive characteristic
52-Week Change +42.76% Strong price performance over the last year

Key valuation takeaways:

  • The P/E band (20.10 trailing vs. 18.77 forward) implies moderate valuation with mild upside expectations priced in.
  • P/B of 2.19 signals investors pay a premium over book value - likely reflecting expected profitability or intangible assets.
  • EV/EBITDA at 15.89 is on the higher side for industrial/chemical names; investors should compare to sector medians for context.
  • Negative EV/FCF (-11.91) requires scrutiny of recent capex, working capital swings or one-off items that depressed free cash flow.
  • Beta 0.58 combined with +42.76% 52-week return suggests the stock delivered strong risk-adjusted gains with lower volatility.

For deeper ownership, shareholder trends and positioning context, see: Exploring Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd. Investor Profile: Who's Buying and Why?

Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd. (600389.SS) - Risk Factors

Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd. operates in a capital-intensive, cyclical industry where market share, input costs and regulatory environments materially affect profitability. Key quantitative indicators underline areas of vulnerability that investors should weigh alongside operational and strategic considerations.
  • Highly competitive global agrochemical market: pressure from multinationals and domestic producers can compress margins and force higher marketing or R&D spend.
  • Concentration risk: heavy reliance on the Chinese market exposes revenue and margins to regional economic slowdowns, commodity cycles and domestic regulatory changes.
  • Leverage considerations: debt-to-equity ratio of 0.51 reflects moderate financial leverage that can amplify stress during revenue declines or rising interest rates.
  • Cash generation challenges: negative free cash flow of CNY -889.42 million signals the company is not currently generating sufficient cash from operations to cover investing and financing needs.
  • Bankruptcy risk profile: an Altman Z-Score of 2.24 places the company in a borderline zone (moderate risk), meaning deteriorating operating performance could rapidly increase default probability.
  • Mixed profitability/quality signals: a Piotroski F-Score of 5 suggests neutral/average financial health - some fundamentals are sound while others raise caution.
Metric Value Implication
Debt-to-Equity 0.51 Moderate leverage; manageable but vulnerable to shocks
Free Cash Flow (recent) CNY -889.42 million Cash burn or significant investment; financing required
Altman Z-Score 2.24 Moderate bankruptcy risk (gray zone)
Piotroski F-Score 5 Neutral; mixed operational & financial signals
Geographic Revenue Concentration Predominantly China Exposure to regional policy and economic cycles
  • Interest rate and refinancing risk: with existing leverage, higher rates or impaired access to capital markets could raise financing costs or constrain operations.
  • Commodity and input-cost volatility: feedstock and raw material price swings can erode gross margins if not passed to customers.
  • Regulatory and environmental compliance risk: stricter environmental rules in China or export markets may require capital expenditure or limit production.
  • Operational disruption risk: production or supply-chain interruptions (e.g., logistics, raw-material shortages) could magnify the cash flow shortfall.
  • M&A / competitive dynamics risk: consolidation by larger chemical groups or aggressive pricing by domestic peers may reduce pricing power.
For investors seeking more context on shareholder composition and directional flows, see: Exploring Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd. Investor Profile: Who's Buying and Why?

Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd. (600389.SS) - Growth Opportunities

Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd. (600389.SS) is positioned to deliver multi‑year expansion driven by product diversification, rising international sales, and operational upgrades. Key forward-looking metrics underpinning this growth thesis include robust forecasts for earnings, revenue, EPS, and return on equity alongside strategic initiatives to scale manufacturing and enhance safety and efficiency.
  • Forecasted earnings growth: 39.1% per annum.
  • Forecasted revenue growth: 18.7% per annum.
  • Forecasted EPS growth: 22.4% per annum.
  • Return on equity (ROE) target: 15.2% within three years.
Market breadth and product structure amplify resilience. The company exports to 40 countries across Asia, Europe, the Americas, and Africa, supporting revenue diversification and foreign-currency exposure that can boost margins when global demand is favorable.
  • International footprint: Exports to 40 countries.
  • Product segments: Intermediate chemicals, advanced materials, flame retardants, microporous insulating boards.
  • Revenue model: Multiple streams from commodity intermediates and higher‑margin specialty advanced materials.
Operational transformation and HSE (Health, Safety, Environment) benchmarking are central to long‑term margin improvement and risk reduction. Investments in intelligent transformation (automation, process control, digital monitoring) and elevating HSE to industry benchmark status aim to reduce downtime, lower incident costs, and attract premium customers.
Metric / Item Current / Forecast Timeframe
Earnings growth (CAGR) 39.1% p.a. Next 3 years
Revenue growth (CAGR) 18.7% p.a. Next 3 years
EPS growth 22.4% p.a. Next 3 years
Return on Equity (forecast) 15.2% 3 years
Export reach 40 countries (Asia, Europe, Americas, Africa) Current
Primary product lines Intermediate chemicals; microporous insulating boards; flame retardants; advanced materials Current
Strategic initiatives Intelligent transformation; HSE benchmarking; capacity expansion Ongoing
Commercial and technical drivers that support the forecasts include scale advantages in intermediate chemicals, higher margin capture from advanced materials, and revenue uplift from export growth. The intelligent transformation program targets productivity and quality gains; HSE benchmarking is expected to reduce insurance and compliance costs while improving uptime.
  • Revenue diversification: commodity + specialty products reduces single‑market reliance.
  • Margin expansion levers: shift to advanced materials and operational efficiency gains.
  • Risk mitigation: stronger HSE lowers incident risk and potential regulatory friction.
For background on the company's history, ownership and how its business model operates, see: Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money

DCF model

Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd. (600389.SS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.